Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy

Medical and Pediatric Oncology
G FountzilasN Pavlidis

Abstract

Possible prognostic variables for tumor response, time to progression (TTP), and survival in 141 patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy were analyzed. None of the variables examined for their possible influence on tumor response attained significance in the stepwise logistic regression. In the univariate analysis, variables found to be strongly associated with TTP were performance status (PS) (P = 0.0301), liver involvement (P = 0.030), and the initial values of WBC (P = 0.0319), lactic dehydrogenase (LDH; P = 0.0053), gamma-glutamyl-transpeptidase (gamma-GT; P = 0.0013), alkaline phosphatase (ALP; P = 0.0186), albumin (P = 0.0004), and carcinoembryonic antigen (CEA; P = 0.0014). In the Cox analysis, liver involvement (P = 0.0553), albumin (P = 0.0181), PS (P = 0.484), and ALP (P = 0.0553) were retained as independently significant variables. When only patients with liver metastases were included in the analysis, then only albumin (P < 0.001) demonstrated a prognostic significance. Also, in the univariate analysis, variables predicting survival were PS (P = 0.0230), grade (P = 0.00600), liver involvement (P = 0.0002), LDH (P = 0.0001), gamma-GT (P < 0.001), ALP (P = ...Continue Reading

References

Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J SteinbergA Wong
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M T NobileL Gallo
May 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Di CostanzoM Bacchi
Jun 26, 1992·Deutsche medizinische Wochenschrift·T M LöfflerG Strohmeyer
Oct 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R LabiancaM Cristoni
Nov 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A PoonJ A Mailliard
Feb 1, 1987·Journal of Surgical Oncology·L M de BrauwA Zwaveling
Oct 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A PoonL K Tschetter
Jan 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M BoccadoroT Barbui
Apr 1, 1989·Journal of Surgical Oncology·A E ChangD E White
Mar 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C ErlichmanT Elhakim
Nov 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C J LahrC M Balch
May 1, 1981·American Journal of Surgery·G BengtssonP E Jönsson
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T R BurokerD H Gesme
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R RossoG Pancera
Jan 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P Piedbois, M Buyse

❮ Previous
Next ❯

Citations

Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C H KöhneH Hecker
Aug 16, 2003·International Journal of Palliative Nursing·Helen Ferns
Jul 15, 2004·European Journal of Clinical Nutrition·D GuptaJ F Grutsch
Apr 11, 2002·American Journal of Clinical Oncology·Yoshihisa NamikiTakashi Ura
May 13, 2003·International Journal of Cancer. Journal International Du Cancer·Maria LiljeforsJan-Erik Frödin
Jun 15, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Joseph Watine, Bruno Friedberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.